7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Myocardial Reperfusion
Myocardial reperfusion is a pivotal component of cardiovascular care, encompassing the reinstatement of blood flow to the heart muscle following a period of ischemia. Ischemia arises when the blood supply to the heart is temporarily diminished or obstructed, often in the context of a myocardial infarction (heart attack). The primary goal of reperfusion is to alleviate ischemic conditions and mitigate damage to the cardiac tissue. Nonetheless, the restoration of blood flow during reperfusion is a double-edged sword. The abrupt reintroduction of oxygen to the ischemic tissue can trigger oxidative stress and inflammation, contributing to additional injury. Striking a balance between the benefits of reperfusion and the potential harm it may cause is a central challenge in managing cardiovascular diseases.
Arthur J Siegel
Massachusetts General Hospital, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Arthur J Siegel
Massachusetts General Hospital, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya